|
⚲
|
| Keyboard |
| Casdin Venture Opportunities Fund GP LLC | |
|---|---|
| Firm | Casdin Capital LLC |
| Address | 1350 Avenue of The Americas Suite 2405 New York, NY 10019 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Casdin Capital LLC | |||||
| Casdin Venture Opportunities Fund LP | 021-306725 | Executive Officer | 30.0 M | 42.7 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Constellation Pharmaceuticals Inc CNST
Common Stock
|
2018-07-23 | Buy | 266,667 | $15.00 | 4,000,005 |
|
Constellation Pharmaceuticals Inc CNST
Common Stock
|
2018-07-23 | Conversion | 345,783 | ||
|
Constellation Pharmaceuticals Inc CNST
Common Stock
|
2018-07-23 | Conversion | 158,960 | ||
|
Constellation Pharmaceuticals Inc CNST
Series F Preferred Stock · derivative
|
2018-07-23 | Conversion | 1,750,000 | $0.00 | |
|
Constellation Pharmaceuticals Inc CNST
Series E Preferred Stock · derivative
|
2018-07-23 | Conversion | 1,333,333 | $0.00 | |
|
Constellation Pharmaceuticals Inc CNST
Series E-1 Preferred Stock · derivative
|
2018-07-23 | Conversion | 342,435 | $0.00 | |
|
Constellation Pharmaceuticals Inc CNST
Series F Preferred Stock · derivative
|
2018-07-23 | Conversion | 1,750,000 | $0.00 |